These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3381222)

  • 1. Pressor response to vasopressin and norepinephrine in DOC-salt hypertensive and prehypertensive rats.
    Ouchi Y; Yazaki Y; Tsai RC; Ashida T
    Tohoku J Exp Med; 1988 Feb; 154(2):125-33. PubMed ID: 3381222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central mechanisms in DOC-salt hypertensive rats.
    Matsuguchi H; Sharabi FM; O'Connor G; Mark AL; Schmid PG
    Clin Exp Hypertens A; 1982; 4(8):1303-21. PubMed ID: 7116668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pressor response to vasopressin and impaired baroreflex function in DOC-salt hypertension.
    Matsuguchi H; Schmid PG
    Am J Physiol; 1982 Jan; 242(1):H44-9. PubMed ID: 7058912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute interaction of vasopressin and neurogenic mechanisms in DOC-salt hypertension.
    Matsuguchi H; Schmid PG
    Am J Physiol; 1982 Jan; 242(1):H37-43. PubMed ID: 7058911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of AVP in malignant DOC-salt hypertension: studies using vascular and antidiuretic antagonists.
    Filep J; Frölich JC; Földes-Filep E
    Am J Physiol; 1987 Nov; 253(5 Pt 2):F952-8. PubMed ID: 3688242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of vasopressin to the maintenance of blood pressure in deoxycorticosterone-salt induced malignant hypertension in spontaneously hypertensive rats.
    Hiwatari M; Abrahams JM; Saito T; Johnston CI
    Clin Sci (Lond); 1986 Feb; 70(2):191-8. PubMed ID: 3956109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pressor responsiveness to vasopressin in the rat with DOC-salt hypertension.
    Crofton JT; Share L; Wang BC; Shade RE
    Hypertension; 1980; 2(4):424-31. PubMed ID: 7399626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contributions of vasopressin and other pressor systems to DOC-salt hypertension in rats.
    Mento PF; Wang HH; Sawyer WH
    Proc Soc Exp Biol Med; 1984 Jan; 175(1):58-63. PubMed ID: 6694969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of endothelin and vasopressin in DOCA-salt hypertension.
    Yu M; Gopalakrishnan V; McNeill JR
    Br J Pharmacol; 2001 Apr; 132(7):1447-54. PubMed ID: 11264238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasopressin and sympathetic nervous functions both contribute to development and maintenance of hypertension in DOCA-salt rats.
    Takata Y; Yamashita Y; Takishita S; Fujishima M
    Clin Exp Hypertens A; 1988; 10(2):203-27. PubMed ID: 3370846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular binding sites and biological activity of vasopressin in DOCA-salt hypertensive rats.
    Larivière R; St-Louis J; Schiffrin EL
    J Hypertens; 1988 Mar; 6(3):211-7. PubMed ID: 3283226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlorthalidone alters the vascular reactivity of DOC-salt hypertensive rats to norepinephrine.
    Musso MN; Vasquez EC; Carvalhinho FB; Bissoli NS; Cabral AM
    Braz J Med Biol Res; 1990; 23(10):999-1003. PubMed ID: 2101067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex difference in pressor responsiveness to vasopressin and baroreflex function in DOC-salt hypertensive rats.
    Ouchi Y; Share L; Crofton JT; Iitake K; Brooks DP
    J Hypertens; 1988 May; 6(5):381-7. PubMed ID: 3385203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of vasopressin in the development and maintenance of DOC-salt hypertension in the rat.
    Crofton JT; Share L; Shade RE; Lee-Kwon WJ; Manning M; Sawyer WH
    Hypertension; 1979; 1(1):31-8. PubMed ID: 544512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does vasopressin contribute to salt-induced hypertension in the Dahl strain?
    Matsuguchi H; Schmid PG; Van Orden D; Mark AL
    Hypertension; 1981; 3(2):174-81. PubMed ID: 7216372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osmotic stimulation in DOC-salt hypertension: vasopressin and blood pressure.
    Crofton JT; Share L; Brooks DP
    J Hypertens; 1986 Jun; 4(3):307-12. PubMed ID: 3734447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responses of mean arterial pressure to pressor agents and diuretics in renal hypertensive and salt hypertensive rats.
    Nicholas TE
    Br J Pharmacol; 1971 Jun; 42(2):179-92. PubMed ID: 4326321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of endothelin on resistance arteries of DOCA-salt hypertensive rats.
    Deng LY; Schiffrin EL
    Am J Physiol; 1992 Jun; 262(6 Pt 2):H1782-7. PubMed ID: 1621836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced contractile sensitivity and vasopressin receptor affinity in DOCA-salt hypertension.
    Bockman CS; Jeffries WB; Pettinger WA; Abel PW
    Am J Physiol; 1992 Jun; 262(6 Pt 2):H1752-8. PubMed ID: 1535757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sodium, deoxycorticosterone and duration of hypertension on pressor responses in rats.
    Bing RF; Russell GI; Swales JD; Thurston H
    J Physiol; 1982 Dec; 333():383-91. PubMed ID: 6763628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.